Department of Immunology, University of Washington School of Medicine, Seattle, WA, 98109, USA.
Department of Immunology, University of Washington School of Medicine, Seattle, WA, 98109, USA.
Curr Opin Immunol. 2020 Feb;62:15-21. doi: 10.1016/j.coi.2019.11.005. Epub 2019 Dec 9.
The varied list of agonists that activate innate lymphoid cells (ILCs) continues to grow, but whether and how these signals interact is not well defined, especially in vivo. ILC subsets share master transcription factors, chromatin landscapes, and effector cytokines with their corresponding T helper (Th) cell subsets. Here we discuss how studies of these two cell types can inform each other. Specifically, we outline a framework in which ILC agonists are grouped by the transcription factors they activate. Optimal ILC activation requires at least three items from a 'menu' of non-redundant signals that collectively replicate the STAT and TCR signaling that drives effector Th cell function. This conceptual model may also apply to TCR-independent 'bystander' activation of Th cells.
激活先天淋巴细胞 (ILC) 的激动剂种类繁多,而且还在不断增加,但这些信号是否以及如何相互作用尚不清楚,尤其是在体内。ILC 亚群与相应的辅助性 T 细胞 (Th) 亚群共享主转录因子、染色质景观和效应细胞因子。在这里,我们讨论了这两种细胞类型的研究如何相互启发。具体来说,我们概述了一个框架,其中将 ILC 激动剂按其激活的转录因子进行分组。最佳的 ILC 激活至少需要来自非冗余信号的“菜单”中的三个项目,这些信号共同复制驱动效应 Th 细胞功能的 STAT 和 TCR 信号。这种概念模型也可能适用于 TCR 非依赖性的“旁观者”Th 细胞激活。